logo

For the Inventor, By the Inventor

Lexington, MA, United States of America

Govinda Rao Bhisetti

This inventor holds 27 USPTO granted patents and 4 published patent applications and 3 EPO patents, primarily in Pharmaceutical Compositions. Top assignee: Vertex Pharmaceuticals, Inc.. Active years: 1996-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Govinda Rao Bhisetti. Retrieved from https://idiyas.com/inventor/govinda-rao-bhisetti

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 27 

% Patents Active = 66.7

 

Average Co-Inventor Count = 3.9

ph-index = 10

Forward Citations = 492(Granted Patents)


Company Filing History:

goldMedal27 out of 1,168 
 
Vertex Pharmaceuticals, Inc.
 patents

Years Active: 1996-2014

Loading Chart...
Loading Chart...
Areas of Expertise:
Benzimidazole Analogues
Serine Protease Inhibitors
HCV NS3 Protease
Sulfonamide Inhibitors
Pharmaceutical Compositions
TACE Inhibitors
Aspartyl Protease
Flavivirus Infections
Co-crystals
Heterocycle Compounds
27 patents (USPTO):Explore Patents
1. 8765731 - Benzimidazole analogues for the treatment or prevention of flavivirus infections (2014-07-01),
2. 8759353 - Co-crystals and pharmaceutical compositions comprising the same (2014-06-24),
3. 8618152 - Inhibitors of serine proteases, particularly HCV NS3-NS4A proteases (2013-12-31),
4. 8354419 - Benzimidazole analogues for the treatment or prevention of flavivirus infections (2013-01-15),
5. 8314141 - Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease (2012-11-20),
6. 7919520 - Inhibitors of tace (2011-04-05),
7. 7608632 - Sulfonamide inhibitors of aspartyl protease (2009-10-27),
8. 7494988 - Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease (2009-02-24),
9. 7485664 - Inhibitors of TACE (2009-02-03),
10. 7388017 - Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease (2008-06-17),
11. 7321063 - Sulfonamide inhibitors of aspartyl protease (2008-01-22),
12. 6720335 - Sulfonamide inhibitors of aspartyl protease (2004-04-13),
13. 6617309 - Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease (2003-09-09),
14. 6608067 - Inhibitors of serine proteases, particularly HCV NS3 protease (2003-08-19),
15. 6392046 - Sulfonamide inhibitors of aspartyl protease (2002-05-21),

Title: Pioneering Innovations: The Inventor Govinda Rao Bhisetti

Introduction: Govinda Rao Bhisetti is a visionary inventor based in Lexington, MA (US), known for his remarkable contributions in the field of pharmaceuticals and viral infections. With a remarkable portfolio of 27 patents, Bhisetti has made significant breakthroughs in the treatment and prevention of flavivirus infections.

Latest Patents: Among his recent patents is the groundbreaking "Benzimidazole analogues for the treatment or prevention of flavivirus infections," which showcases compounds effective in combating flaviviridae viral infections. Additionally, his work on "Co-crystals and pharmaceutical compositions" involving VX-950 highlights innovative methods for enhancing pharmaceutical formulations.

Career Highlights: Govinda Rao Bhisetti is affiliated with Vertex Pharmaceuticals, Inc., a leading pharmaceutical company at the forefront of developing cutting-edge treatments. His tenure at Vertex Pharmaceuticals has been marked by a relentless pursuit of excellence in pharmaceutical research and development.

Collaborations: Bhisetti's collaborative spirit is evident through his partnerships with esteemed colleagues such as Roger D Tung and Mark Andrew Murcko. Together, they have fostered a culture of innovation and teamwork, driving forward advancements in the pharmaceutical industry.

Conclusion: In conclusion, Govinda Rao Bhisetti stands as a beacon of innovation in the realm of pharmaceutical inventions. His dedication to pioneering novel solutions for viral infections exemplifies the transformative impact of inventors in shaping the future of healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…